Symlin and Dyspepsia aggravated - a phase IV clinical study of FDA data

Summary:

Dyspepsia aggravated is reported as a side effect among people who take Symlin (pramlintide acetate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lantus, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Dyspepsia aggravated when taking Symlin. It is created by eHealthMe based on reports of 3,334 people who have side effects when taking Symlin from the FDA, and is updated regularly.

What is Symlin?

Symlin has active ingredients of pramlintide acetate. It is often used in diabetes. eHealthMe is studying from 3,359 Symlin users. Check the latest studies of Symlin.

What is Dyspepsia aggravated?

Dyspepsia aggravated (indigestion) is found to be associated with 1,910 drugs and 513 conditions by eHealthMe. Check the latest studies of Dyspepsia aggravated.

On Jul, 25, 2026

3,334 people reported to have side effects when taking Symlin.
Among them, 62 people (1.86%) have Dyspepsia aggravated.

Could Symlin cause Dyspepsia aggravated?

Among these 62 people:

How long have people been on Symlin when they have Dyspepsia aggravated? *

What is the gender of people who have Dyspepsia aggravated when taking Symlin? *

female: 62.9 %
male: 37.1 %

What is the age of people who have Dyspepsia aggravated when taking Symlin? *

What are other drugs people take besides Symlin? *

What are other side effects people have besides Dyspepsia aggravated? *

Nausea (feeling of having an urge to vomit): 37 people, 59.68%
Blood Glucose Increased: 19 people, 30.65%
Weight Decreased: 17 people, 27.42%
Nausea And Vomiting: 14 people, 22.58%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 13 people, 20.97%
Diarrhea: 13 people, 20.97%
Blood Glucose Decreased: 12 people, 19.35%
Constipation: 12 people, 19.35%
Fatigue (feeling of tiredness): 11 people, 17.74%
Abdominal Distension: 6 people, 9.68%

What are the existing conditions these people have? *

Type 2 Diabetes: 37 people, 59.68%
Nausea And Vomiting: 4 people, 6.45%
Gout (uric acid crystals building up in the body): 4 people, 6.45%
Back Pain: 4 people, 6.45%
Asthma: 4 people, 6.45%
Insulin-Requiring Type 2 Diabetes Mellitus: 3 people, 4.84%
Urinary Bladder Rupture: 2 people, 3.23%
Thyroid Diseases: 2 people, 3.23%
Neuralgia (pain in one or more nerves): 2 people, 3.23%
Nausea (feeling of having an urge to vomit): 2 people, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Symlin and have Dyspepsia aggravated?

- Check whether Dyspepsia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Symlin:

Symlin (3,359 reports)

Browse all side effects of Symlin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspepsia aggravated:

Dyspepsia aggravated (1,911 drugs)

Browse all the conditions that are associated with Dyspepsia aggravated:

Dyspepsia aggravated (513 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pramlintide acetate (the active ingredients of Symlin) and Symlin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.